You are here

  • Home
  • Archive
  • Volume 26, Issue 3
  • An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma

Article info

Article menu
Download PDFPDF
Uterine Cancer
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma

Authors

  1. Address correspondence and reprint requests to Vicky Makker, MD, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065. E-mail: makkerv@mskcc.org.

Citation

Liang LW, Perez AR, Cangemi NA, et al
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma
International Journal of Gynecologic Cancer 2016;26:497-504.

Publication history

  • Received September 11, 2015
  • First published March 1, 2016.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2016 by IGCS and ESGO